This is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.
Opioid Use Disorder
This is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.
LIFU for Treatment for Refractory Opioid Use Disorder
-
WVU Rockefeller Neuroscience Institute, Morgantown, West Virginia, United States, 26505
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
22 Years to 60 Years
ALL
No
Ali Rezai,
Ali Rezai, PRINCIPAL_INVESTIGATOR, Executive Director WVU Rockefeller Neuroscience Institute
2028-03-01